A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin
PM360
NOVEMBER 14, 2023
This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. Currently, an estimated 37.3 of the U.S.
52 
Let's personalize your content